ArticleBone marrow transplantation2025

Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma.

Tim Richardson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.